Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found...
Saved in:
Main Authors: | Yuek Ling Chai, Joyce R. Chong, Ainiah R. Raquib, Xin Xu, Saima Hilal, Narayanaswamy Venketasubramanian, Boon Yeow Tan, Alan P. Kumar, Gautam Sethi, Christopher P. Chen, Mitchell K. P. Lai |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b1b12e90137f45e5a30c6c0e5d07ecd7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
by: Petra Popovics, et al.
Published: (2021) -
Stroke Care in Pakistan
by: Anjum Farooq, et al.
Published: (2021) -
Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression
by: Xing-Xing Yao, et al.
Published: (2017) -
Plasma and follicular fluid osteopontin levels during ovarian cycle and their correlation with follicular fluid vascular endothelial growth factor levels
by: Yoshimitsu Kuwabara, et al.
Published: (2021) -
A Pivotal Role for AP-1-Mediated Osteopontin Expression in the Increased Migration of Vascular Smooth Muscle Cells Stimulated With HMGB1
by: Eun Yeong Jeon, et al.
Published: (2021)